Mechanical properties and performances of contemporary drug-eluting stent: focus on the metallic backbone

ABSTRACT Introduction: Drug-eluting stents (DES) are still the standard of care in percutaneous coronary intervention (PCI) since the fall of bioresorbable scaffolds with respect to safety. The unbeatable advantage of a metallic stent when compared with a scaffold is a stronger mechanical property and more sustainable vascular support. Recent development of contemporary metallic stent has focused on the reduction of strut thickness. However, there will always be a trade-off between improvement in deliverability, flexibility, and radial strength. Areas covered: This review aims to discuss the designs of metallic stent platform and mechanical properties as well as mechanical performance of contemporary DES from bench studies and clinical trials. Expert opinion: Mechanical properties of stents affect short- and long-term clinical outcomes. Ultrathin-strut DES have become popular and clinical trials have shown impressive results. Thinner struts may improve device flexibility and deliverability but the radial strength and longitudinal integrity might have been compromised as well. Ultrathin-strut cobalt chromium or platinum chromium DES will become standard of care in PCI practice in the near future. Information on the stent design, stent material and mechanical properties of the stent are essential for a rational selection of the appropriate stent in selected lesions and patients.

[1]  A. Roguin,et al.  Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents. , 2018, Journal of the American College of Cardiology.

[2]  P. Serruys,et al.  Coronary stent thrombosis: what have we learned? , 2016, Journal of thoracic disease.

[3]  Christian W Hamm,et al.  Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis , 2000, The Lancet.

[4]  W. Carroll,et al.  A platinum-chromium steel for cardiovascular stents. , 2010, Biomaterials.

[5]  H. Ince,et al.  Direct comparison of coronary bare metal vs. drug-eluting stents: same platform, different mechanics? , 2018, European Journal of Medical Research.

[6]  P. Serruys,et al.  Angiographic late lumen loss revisited: impact on long-term target lesion revascularization , 2018, European heart journal.

[7]  G. Stone,et al.  Long-Term Safety of Drug-Eluting and Bare-Metal Stents: Evidence From a Comprehensive Network Meta-Analysis. , 2015, Journal of the American College of Cardiology.

[8]  F. Welt,et al.  Inflammation and Restenosis in the Stent Era , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Kische,et al.  Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[10]  J. Massaro,et al.  Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial , 2017, The Lancet.

[11]  P. Serruys,et al.  An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. , 2010, European heart journal.

[12]  R. Pettigrew,et al.  Absence of movement of coronary stents after placement in a magnetic resonance imaging field. , 1994, The American journal of cardiology.

[13]  K. Seung,et al.  Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort , 2017, Circulation. Cardiovascular interventions.

[14]  J. López-Sendón,et al.  Clinical impact of in-stent late loss after drug-eluting coronary stent implantation. , 2007, European heart journal.

[15]  A. Kastrati,et al.  [Intracoronary Stenting and Angiographic Results Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial]. , 2012, Vestnik rentgenologii i radiologii.

[16]  Ryo Torii,et al.  Local Hemodynamic Forces After Stenting: Implications on Restenosis and Thrombosis , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[17]  R Beyar,et al.  Evaluation of the compressive mechanical properties of endoluminal metal stents. , 1998, Catheterization and cardiovascular diagnosis.

[18]  G. Rioufol,et al.  Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry. , 2016, European heart journal.

[19]  M. Mamas,et al.  Longitudinal deformation bench testing using a coronary artery model: a new standard? , 2017, Open Heart.

[20]  Frank Witte,et al.  The history of biodegradable magnesium implants: a review. , 2010, Acta biomaterialia.

[21]  S. Windecker,et al.  Drug-eluting stent technology: progress beyond the polymer. , 2014, European heart journal.

[22]  G. Biondi-Zoccai,et al.  Last nail in the coffin of late lumen loss? , 2008, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[23]  F. Zijlstra,et al.  Defining optimal stent overexpansion strategies for left main stenting : insights from bench testing , 2017 .

[24]  C. Di Mario,et al.  Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations? , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[25]  M. de Belder,et al.  The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention. , 2016, International journal of cardiology.

[26]  Deepthy Menon,et al.  Nanotextured stainless steel for improved corrosion resistance and biological response in coronary stenting. , 2015, Nanoscale.

[27]  Shuyang Zhang,et al.  Over-expansion of drug-eluting stents in patients with left main coronary artery disease: An in vivo study , 2017, The Journal of international medical research.

[28]  Renu Virmani,et al.  Morphological Predictors of Restenosis After Coronary Stenting in Humans , 2002, Circulation.

[29]  W. Lu,et al.  Surface mechanical properties, corrosion resistance, and cytocompatibility of nitrogen plasma-implanted nickel-titanium alloys: a comparative study with commonly used medical grade materials. , 2007, Journal of biomedical materials research. Part A.

[30]  Yufeng Zheng,et al.  A review on biodegradable materials for cardiovascular stent application , 2016, Frontiers of Materials Science.

[31]  R D Safian,et al.  The Importance of Acute Luminal Diameter in Determining Restenosis After Coronary Atherectomy or Stenting , 1992, Circulation.

[32]  H. Schunkert,et al.  Outcomes of patients treated with durable polymer platinum-chromium everolimus-eluting stents: a meta-analysis of randomised trials. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[33]  Michail I. Papafaklis,et al.  Effects of Low Endothelial Shear Stress After Stent Implantation on Subsequent Neointimal Hyperplasia and Clinical Outcomes in Humans , 2016, Journal of the American Heart Association.

[34]  Sun Kook Yoo,et al.  A comparative reliability and performance study of different stent designs in terms of mechanical properties: foreshortening, recoil, radial force, and flexibility. , 2013, Artificial organs.

[35]  R. Costa,et al.  Comparison of acute stent recoil between the everolimus-eluting bioresorbable vascular scaffold and two different drug-eluting metallic stents , 2013 .

[36]  M. S. Williams,et al.  Stent and artery geometry determine intimal thickening independent of arterial injury. , 2000, Circulation.

[37]  A. Kastrati,et al.  Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. , 2005, European heart journal.

[38]  R. Kempczinski Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty , 1987 .

[39]  J. Ormiston,et al.  Stent Longitudinal Strength Assessed Using Point Compression: Insights From a Second-Generation, Clinically Related Bench Test , 2014, Circulation. Cardiovascular interventions.

[40]  K. Yamaji,et al.  Incidence and Clinical Impact of Stent Fracture After PROMUS Element Platinum Chromium Everolimus-Eluting Stent Implantation. , 2015, JACC. Cardiovascular interventions.

[41]  P. Serruys,et al.  Optical coherence tomography analysis of bioresorbable vascular scaffolds in comparison with metallic stents: A core lab perspective , 2017 .

[42]  Rui Yang,et al.  The Surface Modification Methods for Constructing Polymer-Coated Stents , 2018, International Journal of Polymer Science.

[43]  P. Serruys,et al.  A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial , 2017, The Lancet.

[44]  H. Schunkert,et al.  Five-year outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease: final results from the ISAR-TEST 4 randomised trial. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[45]  F. Eberli,et al.  Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation. , 2012, European heart journal.

[46]  M. Togni,et al.  Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease: Final 5-Year Report From the COMPARE II Trial (Abluminal Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent). , 2017, JACC. Cardiovascular interventions.

[47]  John A Ormiston,et al.  Stent longitudinal integrity bench insights into a clinical problem. , 2011, JACC. Cardiovascular interventions.

[48]  C. Yen,et al.  Quantitative evaluation of susceptibility and shielding effects of nitinol, platinum, cobalt‐alloy, and stainless steel stents , 2003, Magnetic resonance in medicine.

[49]  I. Porto,et al.  Meta‐analysis of bioabsorbable versus durable polymer drug‐eluting stents in 20,005 patients with coronary artery disease: An update , 2014, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[50]  Ryo Torii,et al.  Non-Newtonian pulsatile shear stress assessment: a method to differentiate bioresorbable scaffold platforms. , 2017, European heart journal.

[51]  M. Mamas,et al.  Incidence and mechanisms of longitudinal stent deformation associated with Biomatrix, Resolute, Element, and Xience stents: Angiographic and case‐by‐case review of 1,800 PCIs , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[52]  Bernard Chevalier,et al.  Comparison of in vivo acute stent recoil between the bioresorbable everolimus‐eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus‐eluting stent , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[53]  C. Di Mario,et al.  Importance of knowing stent design threshold diameters and post-dilatation capacities to optimise stent selection and prevent stent overexpansion/incomplete apposition during PCI. , 2013, International Journal of Cardiology.

[54]  Trina Roy,et al.  Computational Modelling and Analysis of Latest Commercially Available Coronary Stents During Deployment , 2014 .

[55]  W Rutsch,et al.  A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. , 1994, The New England journal of medicine.

[56]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[57]  Timothy Watson,et al.  Long and short of optimal stent design , 2017, Open Heart.

[58]  Renu Virmani,et al.  Incidence and predictors of drug-eluting stent fracture in human coronary artery a pathologic analysis. , 2009, Journal of the American College of Cardiology.

[59]  Whole Grain Label Statements Guidance for Industry and FDA Staff , 2006 .

[60]  A. Kastrati,et al.  Predictive Factors of Restenosis After Coronary Implantation of Sirolimus- or Paclitaxel-Eluting Stents , 2006, Circulation.

[61]  Ryo Torii,et al.  Incomplete Stent Apposition Causes High Shear Flow Disturbances and Delay in Neointimal Coverage as a Function of Strut to Wall Detachment Distance: Implications for the Management of Incomplete Stent Apposition , 2014, Circulation. Cardiovascular interventions.

[62]  H. Bezerra,et al.  Impact of acute gain on clinical outcomes of patients treated with sirolimus-eluting stent. - A sub-analysis study from the STLLR trial-. , 2011, Circulation Journal.

[63]  K. Seung,et al.  Incidence and clinical impact of fracture of drug-eluting stents widely used in current clinical practice: comparison with initial platform of sirolimus-eluting stent. , 2012, Journal of cardiology.

[64]  S. Bangalore,et al.  Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents. , 2017, JACC. Cardiovascular interventions.

[65]  R. Whitbourn,et al.  TAXUS ® Element™ stent system , 2011 .

[66]  R. Mongrain,et al.  Coronary Stents Fracture: An Engineering Approach (Review) , 2013 .

[67]  C. Di Mario,et al.  Stent flexibility versus concertina effect: mechanism of an unpleasant trade-off in stent design and its implications for stent selection in the cath-lab. , 2013, International journal of cardiology.

[68]  Tom Duerig,et al.  Self-expanding nitinol stents: material and design considerations , 2004, European Radiology.

[69]  S. Barutçu,et al.  Clinical, angiographic and procedural characteristics of longitudinal stent deformation , 2016, The International Journal of Cardiovascular Imaging.

[70]  Stephen Moore,et al.  Numerical investigations of the haemodynamic changes associated with stent malapposition in an idealised coronary artery. , 2014, Journal of biomechanics.

[71]  Antonio Colombo,et al.  Selection of coronary stents. , 2002, Journal of the American College of Cardiology.

[72]  R. V. van Geuns,et al.  Occurrence and predictors of acute stent recoil—A comparison between the xience prime cobalt chromium stent and the promus premier platinum chromium stent , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[73]  F. Ye,et al.  Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers. , 2016, JACC. Cardiovascular interventions.

[74]  J. Barry,et al.  Strut tissue coverage and endothelial cell coverage: a comparison between bare metal stent platforms and platinum chromium stents with and without everolimus-eluting coating. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[75]  E. Orav,et al.  Late Loss in Lumen Diameter and Binary Restenosis for Drug-Eluting Stent Comparison , 2005, Circulation.

[76]  C. Simonton,et al.  Engineering assessment of the longitudinal compression behaviour of contemporary coronary stents. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[77]  Meng Chen,et al.  Corrosion resistance improvement for 316L stainless steel coronary artery stents by trimethylsilane plasma nanocoatings. , 2014, Journal of biomedical materials research. Part B, Applied biomaterials.

[78]  C. Di Mario,et al.  Over-expansion capacity and stent design model: An update with contemporary DES platforms. , 2016, International journal of cardiology.

[79]  Fred J. Clubb,et al.  INCREASED ARTERY WALL STRESS POST-STENTING LEADS TO GREATER INTIMAL THICKENING , 2010, Laboratory Investigation.

[80]  Michael S. Lee,et al.  Drug‐eluting stent fracture: Incidence, contributing factors, and clinical implications , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[81]  H. Suryapranata,et al.  Short and long-term safety and efficacy of polymer-free vs. durable polymer drug-eluting stents. A comprehensive meta-analysis of randomized trials including 6178 patients. , 2014, Atherosclerosis.

[82]  G. Finet,et al.  Drug-Eluting Stents in Bifurcations: Bench Study of Strut Deformation and Coating Lesions , 2010, Circulation. Cardiovascular interventions.

[83]  H. Schunkert,et al.  Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[84]  J. Ormiston,et al.  Coronary stent durability and fracture: an independent bench comparison of six contemporary designs using a repetitive bend test. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[85]  K. Kadota,et al.  Clinical and angiographic outcomes of axial stent deformations in unrestricted real world patient population , 2017, Journal of interventional cardiology.

[86]  P. Teirstein,et al.  Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial. , 2017, JACC. Cardiovascular interventions.

[87]  Marc D Feldman,et al.  Coronary stents: a materials perspective. , 2007, Biomaterials.

[88]  T. Kume,et al.  Impact of stent platform on longitudinal stent deformation: an in vivo frequency domain optical coherence tomography study , 2017, Cardiovascular Intervention and Therapeutics.

[89]  C. Terkelsen,et al.  Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial. , 2017, JACC. Cardiovascular interventions.

[90]  S. Silber,et al.  Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[91]  M. Maitz,et al.  Plasma-immersion ion-implanted nitinol surface with depressed nickel concentration for implants in blood. , 2006, Journal of biomedical materials research. Part A.

[92]  M. Prince,et al.  Three‐dimensional MR angiography in imaging platinum alloy stents , 2004, Journal of magnetic resonance imaging : JMRI.

[93]  G. Stone,et al.  Intravascular ultrasound assessment of cobalt chromium versus stainless steel drug-eluting stent expansion. , 2010, The American journal of cardiology.

[94]  Wim E Hennink,et al.  Polymer-Free Drug-Eluting Stents: An Overview of Coating Strategies and Comparison with Polymer-Coated Drug-Eluting Stents. , 2015, Bioconjugate chemistry.

[95]  Influence of metal alloy and the profile of coronary stents in patients with multivessel coronary disease , 2011, Clinics.

[96]  M. Mamas,et al.  Longitudinal stent deformation: insights on mechanisms, treatments and outcomes from the Food and Drug Administration Manufacturer and User Facility Device Experience database. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[97]  E. Orav,et al.  Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials , 2005, Circulation.

[98]  R. Virmani,et al.  Comparison of Acute Thrombogenicity for Metallic and Polymeric Bioabsorbable Scaffolds: Magmaris Versus Absorb in a Porcine Arteriovenous Shunt Model , 2017, Circulation. Cardiovascular interventions.

[99]  Seung‐Jung Park,et al.  Intravascular ultrasound comparison of chronic recoil among different stent designs. , 1999, The American journal of cardiology.

[100]  F. Shellock,et al.  Drug eluting coronary stent: in vitro evaluation of magnet resonance safety at 3 Tesla. , 2005, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[101]  C. Dubois,et al.  Clinical utility of platinum chromium bare-metal stents in coronary heart disease , 2015, Medical devices.

[102]  R. Stables,et al.  Stent expansion: a combination of delivery balloon underexpansion and acute stent recoil reduces predicted stent diameter irrespective of reference vessel size , 2006, Heart.

[103]  Bernard Chevalier,et al.  Comparison of in vivo acute stent recoil between the bioabsorbable everolimus‐eluting coronary stent and the everolimus‐eluting cobalt chromium coronary stent: Insights from the ABSORB and SPIRIT trials , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[104]  Effect on Clinical Restenosis of an Ultra-Thin-Strut Bare Metal Cobalt-Chromium Stent Versus a Thin-Strut Stainless Steel Stent. , 2016, Journal of interventional cardiology.

[105]  A. Kastrati,et al.  Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. , 2003, Journal of the American College of Cardiology.

[106]  J. Tanigawa,et al.  The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography. , 2009, International journal of cardiology.

[107]  R. Virmani,et al.  Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[108]  M. Leoncini,et al.  Magmaris: a new generation metallic sirolimus-eluting fully bioresorbable scaffold: present status and future perspectives. , 2017, Journal of thoracic disease.

[109]  M. Stoel,et al.  Three-year safety and efficacy of treating all-comers with newer-generation Resolute Integrity or PROMUS Element stents in the randomised DUTCH PEERS (TWENTE II) trial. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[110]  F. Eberli,et al.  Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease Final 5-Year Report (Limus Eluted From A Durable Versus ERodable Stent Coating) Randomi , 2022 .

[111]  Patrick W Serruys,et al.  Bioresorbable Scaffold: The Advent of a New Era in Percutaneous Coronary and Peripheral Revascularization? , 2011, Circulation.

[112]  R. Shandas,et al.  A Survey of Surface Modification Techniques for Next-Generation Shape Memory Polymer Stent Devices , 2014 .

[113]  A. Kastrati,et al.  Intracoronary Stenting and Angiographic Results: Strut Thickness Effect on Restenosis Outcome (ISAR-STEREO) Trial , 2001, Circulation.

[114]  T. Maruo,et al.  Stent Fracture After Sirolimus-Eluting Stent Implantation: 8-Year Clinical Outcomes , 2015, Circulation. Cardiovascular interventions.

[115]  A. Baszko,et al.  The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform. , 2012, Kardiologia polska.

[116]  R. Wilensky,et al.  Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes: A Report From the National Heart, Lung, and Blood Institute–Sponsored, Multicenter 1985–1986 PTCA and 1997–2006 Dynamic Registries , 2008, Circulation. Cardiovascular interventions.

[117]  Junaid Zafar,et al.  Medical Stents : State of the Art and Future Directions Coronary Stent Materials and Coatings : A Technology and Performance Update , 2015 .

[118]  G. Breithardt,et al.  Relationship of Late Loss in Lumen Diameter to Coronary Restenosis in Sirolimus-Eluting Stents , 2005, Circulation.

[119]  J. Tijssen,et al.  Randomized Multicenter Trial Investigating Angiographic Outcomes of Hybrid Sirolimus-Eluting Stents With Biodegradable Polymer Compared With Everolimus-Eluting Stents With Durable Polymer in Chronic Total Occlusions: The PRISON IV Trial. , 2017, JACC. Cardiovascular interventions.

[120]  E. Edelman,et al.  Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.

[121]  T. Murohara,et al.  Impact of coronary stent designs on acute stent recoil. , 2014, Journal of cardiology.

[122]  G. Stone,et al.  Bare Metal and Drug-Eluting Coronary Stents , 2012 .

[123]  P. Serruys,et al.  How does the failure of Absorb apply to the other bioresorbable scaffolds? An expert review of first-in-man and pivotal trials. , 2019, EuroIntervention.

[124]  M. Joner,et al.  Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography , 2013, Heart.

[125]  R. Virmani,et al.  Endothelial cell recovery between comparator polymer-based drug-eluting stents. , 2008, Journal of the American College of Cardiology.

[126]  C. Terkelsen,et al.  Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[127]  P. E. McHugh,et al.  Comparing coronary stent material performance on a common geometric platform through simulated bench testing. , 2012, Journal of the mechanical behavior of biomedical materials.

[128]  J. Mehilli,et al.  Stent Polymers: Do They Make a Difference? , 2016, Circulation. Cardiovascular interventions.

[129]  Jan J Piek,et al.  Impact of strut thickness on late luminal loss after coronary artery stent placement. , 2004, The American journal of cardiology.

[130]  P. Teirstein,et al.  A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. , 1994, The New England journal of medicine.

[131]  Qiang Ge,et al.  Biodegradable magnesium coronary stents: material, design and fabrication , 2014, Int. J. Comput. Integr. Manuf..

[132]  A. Kastrati,et al.  Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. , 2000, Circulation.

[133]  Y. L. Chen,et al.  Increased corrosion resistance of stent materials by converting current surface film of polycrystalline oxide into amorphous oxide. , 2000, Journal of biomedical materials research.

[134]  N. Lepor Clinical impact of stent design. , 2003, Reviews in cardiovascular medicine.

[135]  P. Serruys,et al.  Delineating the Numerous Causes of Drug-Eluting Stent Restenosis , 2011 .

[136]  P. Erne,et al.  The Road to Bioabsorbable Stents: Reaching Clinical Reality? , 2006, CardioVascular and Interventional Radiology.

[137]  D. Shum-Tim,et al.  Surface and Electrochemical Characterization of IrTi-Oxide Coatings: Towards the Improvement of Radiopacity for Coronary Stent Applications , 2013, International Journal of Electrochemical Science.

[138]  M. Nobuyoshi,et al.  Incidence and Clinical Impact of Stent Fracture After Everolimus-Eluting Stent Implantation , 2012, Circulation. Cardiovascular interventions.

[139]  M. Pfisterer,et al.  A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. , 2007, Journal of the American College of Cardiology.

[140]  R. Virmani,et al.  Engineering aspects of stents design and their translation into clinical practice. , 2007, Annali dell'Istituto superiore di sanita.

[141]  M. Hadamitzky,et al.  Predictive factors of restenosis after coronary stent placement. , 1997, Journal of the American College of Cardiology.

[142]  F. Neumann,et al.  'Ten Commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization. , 2018, European heart journal.

[143]  P. Serruys,et al.  4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE All-Comers trial (A Randomized Comparison of a Zotarolimus-Eluting Stent With an Everolimus-Eluting Stent for Percutaneous Coronary Intervention , 2014, Journal of the American College of Cardiology.

[144]  Antonis Sakellarios,et al.  Impact of local endothelial shear stress on neointima and plaque following stent implantation in patients with ST-elevation myocardial infarction: A subgroup-analysis of the COMFORTABLE AMI-IBIS 4 trial. , 2015, International journal of cardiology.

[145]  Michael Joner,et al.  Vascular Responses to Drug Eluting Stents: Importance of Delayed Healing , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[146]  Patrick W Serruys,et al.  Report of a European Society of Cardiology-European Association of Percutaneous Cardiovascular Interventions task force on the evaluation of coronary stents in Europe: executive summary. , 2015, European heart journal.

[147]  P. Fitzgerald,et al.  Acute stent recoil and optimal balloon inflation strategy: an experimental study using real-time optical coherence tomography. , 2016, EuroIntervention.

[148]  A. Colombo,et al.  A Practical Approach to the Management of Complications During Percutaneous Coronary Intervention. , 2018, JACC. Cardiovascular interventions.

[149]  Robert Langer,et al.  Physical and mechanical properties of PLA, and their functions in widespread applications - A comprehensive review. , 2016, Advanced drug delivery reviews.

[150]  F. Eberli,et al.  Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis , 2014, BMJ : British Medical Journal.

[151]  E. Romagnoli,et al.  Closed versus open cell stent for high-risk percutaneous coronary interventions in ST-elevation acute myocardial infarction: the Closed versus Open Cells stent for High risk percutaneous coronary Interventions in ST-Elevation acute myocardial infarction (COCHISE) pilot study. , 2013, American heart journal.

[152]  L. Topoleski,et al.  A comparison of the mechanical performance characteristics of seven drug‐eluting stent systems , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[153]  E. Edelman,et al.  Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings , 2011, Circulation.

[154]  M. Mamas,et al.  Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms. , 2012, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[155]  M. Nobuyoshi,et al.  Incidence and Clinical Impact of Stent Fracture After the Nobori Biolimus‐Eluting Stent Implantation , 2014, Journal of the American Heart Association.

[156]  C. Jansen,et al.  Stent design related neointimal tissue proliferation in human coronary arteries; an intravascular ultrasound study. , 2001, European heart journal.

[157]  P. Gurbel,et al.  Could stent design affect platelet activation? Results of the Platelet Activation in STenting (PAST) Study. , 2002, The Journal of invasive cardiology.

[158]  Gregg W Stone,et al.  A prospective, randomized evaluation of a novel everolimus-eluting coronary stent: the PLATINUM (a Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System [PROMUS Element] for the Treatment of Up to Two de Novo Coronary Artery Lesions) trial. , 2011, Journal of the American College of Cardiology.

[159]  H. Bøtker,et al.  Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial). , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[160]  Ryo Torii,et al.  Impact of stent strut design in metallic stents and biodegradable scaffolds. , 2014, International journal of cardiology.

[161]  S. Bangalore Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease , 2016, The New England journal of medicine.

[162]  P. Barragan,et al.  Longitudinal compression behaviour of coronary stents: a bench-top comparative study. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.